Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Karabelas Argeris N
Relationship:  
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   130,211    

Indirect Shares

  3,405,909      
Direct Value   $904,788    

Indirect Value

  $48,548,603      
Total Shares   3,536,120      
Total Value   $49,453,391      


Bausch Health Companies Inc
 $811,570 Regenxbio Inc.
 $93,218 Bausch Health Companies Inc
 $811,570 Regenxbio Inc.
 $93,218
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Anadys Pharmaceuticals Inc ANDS Director 0 2004-03-18 1,128,770    Premium*  
            Vanda Pharmaceuticals Inc. VNDA Director 0 2010-03-12 0    Premium*  
            Biodelivery Sciences Internation... BDSI 10% Owner 2009-06-17 0 2009-07-16 0    Premium*  
            Human Genome Sciences Inc HGSI Director 2012-07-30 0 2006-11-10 0    Premium*  
            Rocket Pharmaceuticals RCKT Director, 10% Owner 0 2015-02-23 2,277,139    Premium*  
            Bausch Health Companies Inc BHC Director 2022-06-24 123,715 2016-06-17 0    Premium*  
            Regenxbio Inc. RGNX 2023-06-02 6,496 2022-06-03 0    Premium*  
* Premium Members only  

Records found :    66         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
HGSI Human Genome Sciences Inc Director   •       •      –    2012-07-30 4 D $14.25 $59,366 D/D (4,166) 17,776 0 -
HGSI Human Genome Sciences Inc Director   •       •      –    2012-07-30 4 D $14.25 $253,308 D/D (17,776) 0 0 -
RCKT Rocket Pharmaceuticals Director   –       •       •   2015-02-17 3 IO $0.00 $0 I/I 0 215,102 -
RCKT Rocket Pharmaceuticals Director   –       •       •   2015-02-23 4 A $0.00 $0 I/I 1,458,205 1,673,307 0 -
RCKT Rocket Pharmaceuticals Director   –       •       •   2015-02-23 4 B $6.00 $3,622,992 I/I 603,832 2,277,139 2.25 -
BHC Bausch Health Companies I... Director   –       •      –    2016-06-17 4 A $0.00 $0 D/D 16,726 16,726 0 -
BHC Bausch Health Companies I... Director   –       •      –    2016-08-11 4 B $24.65 $98,600 D/D 4,000 20,726 2.39 -
BHC Bausch Health Companies I... Director   –       •      –    2017-05-05 4 A $0.00 $0 D/D 25,406 46,132 0 -
BHC Bausch Health Companies I... Director   •       •      –    2018-05-03 4 A $0.00 $0 D/D 14,285 60,417 0 -
BHC Bausch Health Companies I... Director   •       •      –    2018-05-03 4/A A $0.00 $0 D/D 13,881 60,013 0 -
BHC Bausch Health Companies I... Director   •       •      –    2019-05-03 4 A $23.51 $249,982 D/D 10,633 70,646 0 -
BHC Bausch Health Companies I... Director   •       •      –    2020-05-01 4 A $0.00 $0 D/D 11,037 81,683 0 -
BHC Bausch Health Companies I... Director   •       •      –    2021-04-30 4 A $0.00 $0 D/D 7,645 89,328 0 -
RGNX Regenxbio Inc.   –       •      –    2022-06-03 4 A $0.00 $0 D/D 3,010 3,010 0 -
BHC Bausch Health Companies I... Director   •       •      –    2022-06-24 4 A $0.00 $0 D/D 34,387 123,715 0 -
RGNX Regenxbio Inc.   –       •      –    2023-06-02 4 A $0.00 $0 D/D 3,486 6,496 0 -

  66  Records found
  1   2   3     
  Page 3 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed